Infectious Disease Topics
RSSArticles
-
Even Moderate COVID-19 Cases Can Cause Serious Neurological Problems
Strokes, seizures, and movement disorders just a few complications observed.
-
Bamlanivimab Injection
Bamlanivimab is a neutralizing recombinant IgG1 monoclonal antibody that connects to the receptor-binding domain of the spike protein of SARS-CoV-2. The drug blocks attachment and entry of the virus into human cells.
-
Rifampin vs. Isoniazid for Latent Tuberculosis
A health system cost comparison showed that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.
-
FDA Issues Third COVID-19 Therapeutic EUA This Month
The list of COVID-19 therapeutics is growing rapidly.
-
AMA Prepares for COVID-19 Vaccine with Coding Updates
There are codes unique to two possible vaccines and other unique codes concerning administration of those vaccines.
-
Analysis: Nurses at High Risk of Contracting COVID-19
Investigators emphasized the need for rigorous infection control practices in healthcare settings as well as mitigation efforts aimed at reducing transmission of the virus in the community.
-
Tips for Successfully Implementing a Flu Vaccination Program
Pediatric ED leaders interested in implementing a screening protocol to boost flu vaccination rates in children should rely on quality improvement principles.
-
Nurse-Driven Screening Protocol Seeks Flu Vaccine for Every Eligible Child in ED
Frustrated with low vaccination rates, the ED at Children’s Wisconsin in Milwaukee implemented a screening protocol to offer the flu vaccine to every eligible child who presents for care. Now in its third year, the nurse-driven intervention has proven successful, with leaders working to expand the approach ahead of an expected COVID-19 vaccine.
-
Infectious Disease Alert Updates
Fatal ESBL Infection from Fecal Microbiota Transplant; Second Joint Infection When One Prosthetic Gets Infected?
-
Predictors of Therapy Outcomes for Cryptococcal Meningitis: Failure of In Vitro Susceptibility Testing, Success of Early Fungicidal Activity
Although in vitro susceptibility testing failed to have value in predicting therapeutic outcome in patients with cryptococcal meningitis, detection of a rapid decline in fungal density in cerebrospinal fluid was associated with improved outcomes in a separate study.